id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-1995-S-0036-0203,FDA,FDA-1995-S-0036,Table of Contents,Other,Background Material,2021-12-13T05:00:00Z,2021,12,2022-01-02T05:00:00Z,,2022-01-02T05:58:23Z,,0,0,0900006484ec1d33
FDA-1995-S-0036-0205,FDA,FDA-1995-S-0036,UPMC Children’s Hospital of Pittsburgh Community Consultation & Public Disclosure Plan,Other,Background Material,2021-12-13T05:00:00Z,2021,12,2022-01-02T05:00:00Z,,2022-01-02T06:12:55Z,,0,0,0900006484ec1d37
FDA-1995-S-0036-0204,FDA,FDA-1995-S-0036,Submission Cover Letter,Other,Background Material,2021-12-13T05:00:00Z,2021,12,2022-01-02T05:00:00Z,,2022-01-02T06:12:00Z,,0,0,0900006484ec1d35
FDA-1995-S-0036-0197,FDA,FDA-1995-S-0036,Table of Contents,Other,Background Material,2021-10-26T04:00:00Z,2021,10,2021-10-26T04:00:00Z,,2021-10-26T17:28:19Z,,0,0,0900006484df8a3b
FDA-1995-S-0036-0200,FDA,FDA-1995-S-0036,Community Consultation & Public Disclosure Plan from Baylor College of Medicine,Other,Letter(s),2021-10-26T04:00:00Z,2021,10,2021-10-26T04:00:00Z,,2021-10-26T17:45:24Z,,0,0,0900006484df8a41
FDA-1995-S-0036-0202,FDA,FDA-1995-S-0036,Community Consultation & Public Disclosure Plan FROM Children’s Hospital Los Angeles,Other,Letter(s),2021-10-26T04:00:00Z,2021,10,2021-10-26T04:00:00Z,,2021-10-26T17:50:57Z,,0,0,0900006484df8a45
FDA-1995-S-0036-0198,FDA,FDA-1995-S-0036,Cover Letter,Other,Letter(s),2021-10-26T04:00:00Z,2021,10,2021-10-26T04:00:00Z,,2021-10-26T17:29:28Z,,0,0,0900006484df8a3d
FDA-1995-S-0036-0199,FDA,FDA-1995-S-0036,Community Consultation & Public Disclosure Plan from Children’s Wisconsin,Other,Letter(s),2021-10-26T04:00:00Z,2021,10,2021-10-26T04:00:00Z,,2021-10-26T17:41:45Z,,0,0,0900006484df8a3f
FDA-1995-S-0036-0201,FDA,FDA-1995-S-0036,"Community Consultation & Public Disclosure Plan from Children’s Medical Center, Dallas/University of Texas, Southwestern",Other,Letter(s),2021-10-26T04:00:00Z,2021,10,2021-10-26T04:00:00Z,,2021-10-26T17:48:13Z,,0,0,0900006484df8a43
FDA-1995-S-0036-0194,FDA,FDA-1995-S-0036,Public Disclosure from The Children’s Hospital of Philadelphia,Other,Public Disclosure,2021-09-24T04:00:00Z,2021,9,2021-09-24T04:00:00Z,,2021-10-01T05:12:29Z,,0,0,0900006484d99c13
FDA-1995-S-0036-0192,FDA,FDA-1995-S-0036,Public Disclosure from The Children’s Hospital of Philadelphia,Other,Public Disclosure,2021-09-24T04:00:00Z,2021,9,2021-09-24T04:00:00Z,,2021-10-01T05:10:18Z,,0,0,0900006484d8e908
FDA-1995-S-0036-0191,FDA,FDA-1995-S-0036,Public Disclosure Report from Beth Israel Deaconess Medical Center,Other,Public Disclosure,2021-09-24T04:00:00Z,2021,9,2021-10-01T04:00:00Z,,2021-10-01T05:05:53Z,,0,0,090000648309ad33
FDA-1995-S-0036-0196,FDA,FDA-1995-S-0036,"Public Disclosure Report from Kelly Hoy, Diffusion Pharmaceuticals Inc. -  duplication of FDA-1995-S-0036-0190",Other,Public Disclosure,2021-09-24T04:00:00Z,2021,9,2021-09-24T04:00:00Z,,2021-10-01T05:14:11Z,,0,0,090000648435aaeb
FDA-1995-S-0036-0195,FDA,FDA-1995-S-0036,Public Disclosure from The Children’s Hospital of Philadelphia,Other,Public Disclosure,2021-09-24T04:00:00Z,2021,9,2021-10-01T04:00:00Z,,2021-10-01T05:13:02Z,,0,0,0900006484d99c60
FDA-1995-S-0036-0193,FDA,FDA-1995-S-0036,Public Disclosure from The Children’s Hospital of Philadelphia,Other,Public Disclosure,2021-09-24T04:00:00Z,2021,9,2021-09-24T04:00:00Z,,2021-10-01T05:11:56Z,,0,0,0900006484d99bc0
FDA-1995-S-0036-0190,FDA,FDA-1995-S-0036,Re: Prehospital Airway Control Trial (PACT),Supporting & Related Material,Background Material,2021-09-08T04:00:00Z,2021,9,,,2021-09-08T16:04:59Z,,0,0,0900006484d60e22
FDA-1995-S-0036-0189,FDA,FDA-1995-S-0036,University of Michigan Dept of Emergency Medicine End of study and Post-Trial Public Disclosure Report for IDE G160263,Other,Supplement (SUP),2021-06-17T04:00:00Z,2021,6,2021-06-17T04:00:00Z,,2021-06-17T12:58:51Z,,0,0,0900006484b904ec
FDA-1995-S-0036-0188,FDA,FDA-1995-S-0036,"Public Disclosure from Scott L. Weiss, MD MSCE",Other,Public Disclosure,2021-05-25T04:00:00Z,2021,5,2021-05-25T04:00:00Z,,2021-05-25T15:35:46Z,,0,0,0900006482ce9ef1
FDA-1995-S-0036-0181,FDA,FDA-1995-S-0036,"ESETT, Neurological Emergencies Treatment Trials (NETT) Network Report of Pre-trial Public Disclosure IND #119,756",Other,Public Disclosure,2021-02-05T05:00:00Z,2021,2,2021-02-05T05:00:00Z,,2021-02-05T14:57:36Z,,0,0,0900006482b19fd4
FDA-1995-S-0036-0180,FDA,FDA-1995-S-0036,"ESETT, Neurological Emergencies Treatment Trials (NETT) & PECARN Networks Summary Report of Community Consultations for Public Disclosure IND #119,756",Other,Public Disclosure,2021-02-05T05:00:00Z,2021,2,2021-02-05T05:00:00Z,,2021-02-05T14:57:28Z,,0,0,0900006482b19b84
FDA-1995-S-0036-0182,FDA,FDA-1995-S-0036,"ESETT, Neurological Emergencies Treatment Trials (NETT) & PECARN Networks Examples of Public Disclosure Materials IND #119,756",Other,Public Disclosure,2021-02-05T05:00:00Z,2021,2,2021-02-05T05:00:00Z,,2021-02-05T14:57:41Z,,0,0,0900006482b19fd6
FDA-1995-S-0036-0183,FDA,FDA-1995-S-0036,"Public Disclosure from Jason L Sperry, MD, MPH",Other,Public Disclosure,2021-02-05T05:00:00Z,2021,2,2021-02-05T05:00:00Z,,2021-02-05T14:57:45Z,,0,0,0900006482b6c6a1